Dynavax Technologies (DVAX) Short Interest Ratio & Short Volume $12.39 -0.09 (-0.72%) Closing price 04:00 PM EasternExtended Trading$12.38 -0.01 (-0.08%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Dynavax Technologies Short Interest DataDynavax Technologies (DVAX) has a short interest of 17.13 million shares. This marks a 2.09% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 1.98 million shares to cover all short positions.Current Short Interest17,130,000 sharesPrevious Short Interest16,780,000 sharesChange Vs. Previous Month+2.09%Dollar Volume Sold Short$218.75 millionShort Interest Ratio7.8 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares131,460,000 sharesPercentage of Shares Shorted13.03%Today's Trading Volume1,290,391 sharesAverage Trading Volume1,979,409 sharesToday's Volume Vs. Average65% Short Selling Dynavax Technologies? Sign up to receive the latest short interest report for Dynavax Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDVAX Short Interest Over TimeDVAX Days to Cover Over TimeDVAX Percentage of Float Shorted Over Time Dynavax Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202417,130,000 shares $218.75 million +2.1%N/A7.8 $12.77 12/15/202416,780,000 shares $217.47 million -6.3%N/A8 $12.96 11/30/202417,900,000 shares $230.19 million -14.8%N/A8.2 $12.86 11/15/202421,000,000 shares $256.41 million +11.5%N/A9.2 $12.21 10/31/202418,840,000 shares $223.25 million +10.4%N/A9 $11.85 10/15/202417,060,000 shares $183.57 million +0.1%N/A8.3 $10.76 Get the Latest News and Ratings for DVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dynavax Technologies and its competitors with MarketBeat's FREE daily newsletter. 9/30/202417,040,000 shares $189.83 million -5.6%N/A8.5 $11.14 9/15/202418,050,000 shares $201.62 million -1.4%N/A8.6 $11.17 8/31/202418,300,000 shares $205.33 million -3.3%N/A8.3 $11.22 8/15/202418,930,000 shares $214.67 million +5.8%N/A8.5 $11.34 7/31/202417,890,000 shares $200.19 million +4.0%N/A7.7 $11.19 7/15/202417,210,000 shares $181.74 million -4.7%N/A8 $10.56 6/30/202418,060,000 shares $202.81 million -18.1%N/A8 $11.23 6/15/202422,060,000 shares $254.79 million +3.1%N/A10.4 $11.55 5/31/202421,390,000 shares $256.47 million -5.8%N/A10.2 $11.99 5/15/202422,700,000 shares $250.61 million +15.7%N/A11 $11.04 4/30/202419,620,000 shares $223.08 million +5.8%N/A10 $11.37 4/15/202418,540,000 shares $216.73 million +3.2%N/A9.6 $11.69 3/31/202417,970,000 shares $223.01 million +3.6%N/A9.2 $12.41 3/15/202417,350,000 shares $209.07 million +6.0%N/A8.9 $12.05 2/29/202416,370,000 shares $207.41 million +9.1%N/A8.6 $12.67 2/15/202415,000,000 shares $187.20 million +4.7%N/A8 $12.48 1/31/202414,330,000 shares $185.14 million -1.2%N/A8 $12.92 1/15/202414,510,000 shares $202.12 million -2.9%13.9%8.1 $13.93 12/31/202314,950,000 shares $209.00 million +1.6%N/A9.1 $13.98 12/15/202314,710,000 shares $200.94 million +9.0%N/A9.2 $13.66 11/30/202313,490,000 shares $184.81 million -2.7%N/A8.8 $13.70 11/15/202313,860,000 shares $187.53 million -0.1%N/A9.1 $13.53 10/31/202313,870,000 shares $197.09 million +5.8%N/A9.2 $14.21 10/15/202313,110,000 shares $186.69 million -12.9%N/A8 $14.24 9/30/202315,050,000 shares $222.29 million +2.7%N/A9 $14.77 9/15/202314,660,000 shares $200.11 million +4.5%N/A8.4 $13.65 8/31/202314,030,000 shares $201.47 million -4.4%N/A7.7 $14.36 8/15/202314,670,000 shares $210.66 million -13.8%N/A8.2 $14.36 7/31/202317,020,000 shares $238.11 million -6.0%N/A9.5 $13.99 7/15/202318,110,000 shares $251.91 million -14.3%N/A11.6 $13.91 6/30/202321,140,000 shares $273.13 million +1.4%N/A14.3 $12.92 6/15/202320,840,000 shares $270.09 million +11.4%N/A15.7 $12.96 5/31/202318,700,000 shares $213.74 million +1.9%N/A15 $11.43 5/15/202318,360,000 shares $210.41 million +1.8%N/A13.2 $11.46 4/30/202318,040,000 shares $187.80 million -0.2%N/A13.1 $10.41 4/15/202318,070,000 shares $200.94 million -0.9%N/A12.8 $11.12 3/31/202318,230,000 shares $178.84 million +2.2%N/A12.6 $9.81 3/15/202317,840,000 shares $173.94 million +10.4%N/A12 $9.75 2/28/202316,160,000 shares $166.45 million -13.3%N/A10 $10.30 2/15/202318,640,000 shares $213.43 million +25.5%N/A11.7 $11.45 1/31/202314,850,000 shares $168.99 million +12.8%N/A9.1 $11.38 1/15/202313,170,000 shares $149.48 million +2.9%N/A7.5 $11.35 12/30/202212,800,000 shares $136.19 million -7.3%N/A7.2 $10.64 12/15/202213,800,000 shares $153.87 million -0.1%N/A7.4 $11.15 11/30/202213,820,000 shares $171.51 million -12.1%N/A7.4 $12.41 11/15/202215,730,000 shares $206.22 million +9.2%N/A8.5 $13.11 10/31/202214,400,000 shares $164.88 million -17.8%N/A6.8 $11.45 10/15/202217,520,000 shares $187.64 million +3.0%N/A8 $10.71 9/30/202217,010,000 shares $177.58 million +7.5%N/A8.2 $10.44 9/15/202215,830,000 shares $182.20 million +0.9%N/A7.7 $11.51 8/31/202215,690,000 shares $179.96 million -7.7%N/A7.5 $11.47 8/15/202217,000,000 shares $265.54 million -5.5%N/A7.3 $15.62 7/31/202217,990,000 shares $258.70 million -7.2%N/A6.1 $14.38 7/15/202219,380,000 shares $280.23 million +2.3%N/A6.8 $14.46 6/30/202218,950,000 shares $238.58 million -2.9%N/A6.6 $12.59 6/15/202219,510,000 shares $208.17 million +2.3%31.5%6.9 $10.67 5/31/202219,070,000 shares $226.17 million +8.2%N/A7 $11.86 5/15/202217,630,000 shares $169.25 million No ChangeN/A6.8 $9.60 4/30/202217,630,000 shares $155.67 million +3.0%N/A10.6 $8.83 4/15/202217,120,000 shares $179.93 million +1.0%N/A10.3 $10.51 3/31/202216,950,000 shares $183.74 million -0.7%N/A9.7 $10.84 3/15/202217,070,000 shares $178.21 million +3.3%N/A9.5 $10.44 2/28/202216,520,000 shares $202.54 million +2.2%N/A8.8 $12.26 2/15/202216,160,000 shares $215.25 million -0.9%14.6%8.7 $13.32 1/31/202216,310,000 shares $211.54 million +4.0%14.7%8.2 $12.97 1/15/202215,690,000 shares $212.29 million +1.2%N/A6.8 $13.53 12/31/202115,510,000 shares $218.23 million -5.5%13.9%6.6 $14.07 12/15/202116,420,000 shares $232.34 million +4.3%14.8%6.1 $14.15 11/30/202115,750,000 shares $254.36 million +3.5%14.2%4.4 $16.15 11/15/202115,220,000 shares $259.50 million -20.2%13.7%3.2 $17.05 10/29/202119,060,000 shares $380.63 million -3.4%17.2%3.9 $19.97 10/15/202119,730,000 shares $334.23 million -2.0%18.6%4.1 $16.94 9/30/202120,130,000 shares $386.70 million -5.9%19.0%4.4 $19.21 9/15/202121,400,000 shares $309.87 million -7.8%20.2%4.9 $14.48 8/31/202123,200,000 shares $451.47 million +14.4%21.9%6.7 $19.46 8/13/202120,280,000 shares $267.70 million +1.2%19.2%9.3 $13.20 7/30/202120,050,000 shares $187.27 million +5.6%19.0%8.8 $9.34 7/15/202118,990,000 shares $179.27 million +4.6%18.0%8.6 $9.44 6/30/202118,150,000 shares $178.78 million +3.4%17.2%7.3 $9.85 6/15/202117,550,000 shares $156.02 million -0.6%16.6%7 $8.89 5/28/202117,660,000 shares $144.81 million -3.7%17.1%6.5 $8.20 5/14/202118,340,000 shares $134.43 million +14.1%N/A5.8 $7.33 4/30/202116,080,000 shares $168.20 million -14.0%N/A4.4 $10.46 4/15/202118,700,000 shares $189.62 million +1.7%N/A3.2 $10.14 3/31/202118,390,000 shares $171.39 million -16.2%N/A3.2 $9.32 3/15/202121,950,000 shares $210.28 million +7.8%N/A3.6 $9.58 2/26/202120,360,000 shares $166.14 million -4.0%N/A3.4 $8.16 2/12/202121,210,000 shares $202.13 million -5.3%N/A3.7 $9.53 1/29/202122,400,000 shares $132.16 million -4.7%N/A4 $5.90 1/15/202123,510,000 shares $120.84 million +2.9%N/A7.6 $5.14 12/31/202022,850,000 shares $111.97 million -6.4%N/A7.6 $4.90 12/15/202024,410,000 shares $126.20 million -8.8%N/A8.3 $5.17 11/30/202026,750,000 shares $128.13 million -2.9%N/A8.4 $4.79 11/15/202027,560,000 shares $114.65 million -4.2%N/A8.4 $4.16 10/30/202028,760,000 shares $112.16 million +8.5%N/A8.1 $3.90 10/15/202026,510,000 shares $121.68 million +1.8%N/A6.4 $4.59 9/30/202026,030,000 shares $112.45 million +44.5%N/A5.2 $4.32 9/15/202018,020,000 shares $96.41 million +5.0%N/A3 $5.35 8/31/202017,170,000 shares $102.68 million +1.1%N/A2.9 $5.98 8/14/202016,990,000 shares $114.17 million +2.9%N/A2.4 $6.72 7/31/202016,520,000 shares $133.98 million +22.3%N/A2.1 $8.11 7/15/202013,510,000 shares $124.16 million -11.4%N/A1.8 $9.19 6/30/202015,240,000 shares $135.18 million +21.1%N/A2.4 $8.87 6/15/202012,580,000 shares $80.76 million +9.1%N/A2.3 $6.42 5/29/202011,530,000 shares $70.56 million -3.4%N/A2.3 $6.12 5/15/202011,930,000 shares $54.28 million +4.5%N/A3.5 $4.55 4/30/202011,420,000 shares $48.54 million +4.5%N/A5.6 $4.25 4/15/202010,930,000 shares $33.66 million -2.9%N/A6.5 $3.08 3/31/202011,260,000 shares $38.28 million -18.4%N/A7.7 $3.40 3/13/202013,802,500 shares $40.58 million +8.0%N/A8.2 $2.94 2/28/202012,780,000 shares $40.00 million -14.9%N/A9.5 $3.13 2/14/202015,020,000 shares $56.33 million -5.4%N/A11.7 $3.75 1/31/202015,880,000 shares $68.28 million -1.3%N/A12.4 $4.30 DVAX Short Interest - Frequently Asked Questions What is Dynavax Technologies' current short interest? Short interest is the volume of Dynavax Technologies shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 17,130,000 shares of DVAX short. Learn More on Dynavax Technologies' current short interest. What is a good short interest ratio for Dynavax Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DVAX shares currently have a short interest ratio of 8.0. Learn More on Dynavax Technologies's short interest ratio. Which institutional investors are shorting Dynavax Technologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dynavax Technologies: Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Dynavax Technologies' short interest increasing or decreasing? Dynavax Technologies saw a increase in short interest in December. As of December 31st, there was short interest totaling 17,130,000 shares, an increase of 2.1% from the previous total of 16,780,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dynavax Technologies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biotechnology" compare to Dynavax Technologies: Ionis Pharmaceuticals, Inc. (7.49%), Alkermes plc (6.76%), Amicus Therapeutics, Inc. (6.48%), Ligand Pharmaceuticals Incorporated (4.76%), Geron Co. (10.76%), MannKind Co. (10.78%), BioCryst Pharmaceuticals, Inc. (7.59%), Celldex Therapeutics, Inc. (12.19%), Novavax, Inc. (23.05%), Myriad Genetics, Inc. (5.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Dynavax Technologies stock? Short selling DVAX is an investing strategy that aims to generate trading profit from Dynavax Technologies as its price is falling. DVAX shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dynavax Technologies? A short squeeze for Dynavax Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DVAX, which in turn drives the price of the stock up even further. How often is Dynavax Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DVAX, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Ionis Pharmaceuticals Short Interest Data Alkermes Short Interest Data Amicus Therapeutics Short Interest Data Ligand Pharmaceuticals Short Interest Data Geron Short Interest Data MannKind Short Interest Data BioCryst Pharmaceuticals Short Interest Data Celldex Therapeutics Short Interest Data Novavax Short Interest Data Myriad Genetics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DVAX) was last updated on 1/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynavax Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
